Home/Filings/4/0001209191-16-091478
4//SEC Filing

ProNAi Therapeutics Inc 4

Accession 0001209191-16-091478

CIK 0001290149operating

Filed

Jan 13, 7:00 PM ET

Accepted

Jan 14, 5:16 PM ET

Size

11.5 KB

Accession

0001209191-16-091478

Insider Transaction Report

Form 4
Period: 2016-01-12
Lovejoy Chandra D
SVP of Reg. Affairs & Quality
Transactions
  • Exercise/Conversion

    Common Stock

    2016-01-12$0.97/sh+7,551$7,31720,973 total
  • Sale

    Common Stock

    2016-01-12$11.93/sh5,562$66,3450 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2016-01-127,55146,140 total
    Exercise: $0.97Exp: 2024-09-22Common Stock (7,551 underlying)
  • Sale

    Common Stock

    2016-01-12$11.06/sh15,411$170,4895,562 total
Footnotes (4)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.57 to $11.56 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.57 to $12.22 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F4]The option vests as to 25% of the total shares on September 29, 2015, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on September 29, 2018, subject to the reporting person's provision of service to the issuer on each vesting date. The option is immediately exercisable.

Issuer

ProNAi Therapeutics Inc

CIK 0001290149

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001290149

Filing Metadata

Form type
4
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 5:16 PM ET
Size
11.5 KB